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Abstract
Background: Patients with Alzheimer’s disease and related dementias (ADRD) and traumatic brain injury (TBI) and
their caregivers require cognitive and behavioral symptom management, interdisciplinary care, support for caregivers,
and seamless care coordination between providers. Caring for someone with ADRD or TBI is associated with higher
rates of psychological morbidity and burden, social isolation, financial hardship, and deterioration of physical health.
Tremendous need exists for primary care–based interventions that concurrently address the care needs of dyads and
aim to improve care and outcomes for both individuals with ADRD and TBI and their family caregivers.
Methods: The Aging Brain Care Acquiring New Skills While Enhancing Remaining Strengths (ABC ANSWERS) study is a
randomized controlled trial that tests the effectiveness of an intervention based on two evidence-based programs that
have been developed for and previously tested in populations with ADRD, TBI, stroke, and late-life depression and/or who
have survived an intensive care unit stay. This study includes 200 dyads comprised of a veteran with a diagnosis of ADRD
or TBI and the veteran’s primary informal caregiver. Dyads are randomized to receive the ABC ANSWERS intervention or
routine Veterans Health Administration (VHA) primary care with a standardized educational and resource information
packet. Data collection occurs at baseline and three follow-up time points (3months, 6months, and 12months). The
primary outcome is caregiver quality of life (QoL). A secondary measure for the caregiver is caregiver burden. Secondary
measures for both the veteran and caregiver include symptoms of depression and anxiety.
Discussion: The ABC ANSWERS intervention integrates common features of an evidence-based collaborative care model
for brain health while concurrently attending to the implementation barriers of delivering care and skills to dyads. We
hypothesize that caregivers in dyads randomized to the ABC ANSWERS program will experience higher levels of QoL and
lower levels of depression, anxiety, dyadic strain, and caregiver burden at 12months than those receiving usual VHA
primary care.
Trial registration: ClinicalTrials.gov, NCT03397667. Registered on 12 January 2018.
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Background
The number of Americans aged 65 years or older with
Alzheimer’s disease and related dementias (ADRD) is ex-
pected to grow to more than 13.8 million by 2050 [1].
Although the prevalence of ADRD in veterans is cur-
rently similar to that in the overall population, it is an-
ticipated to grow dramatically as the population ages
and as a result of the increased incidence of traumatic
brain injury (TBI), a known risk factor for developing
ADRD [2, 3]. Of the more than 2.3 million soldiers who
have been deployed to Iraq and/or Afghanistan [1], 379,
519 have been diagnosed with TBI since 2000 [4]. Indi-
viduals who experience multiple concussions or sustain
a single moderate to severe-TBI have a two- to fourfold
increased risk of developing subsequent neurodegenera-
tive diseases [5]. Furthermore, a history of TBI within
10 years of an ADRD diagnosis is associated with more
rapid functional impairment progression [6].
Individuals with ADRD and TBI experience increasing
cognitive and functional limitations that may induce
symptoms of depression and anxiety. A recent systemic
review and meta-analysis reported an overall prevalence of
49% for apathy in patients with ADRD, whereas 42% had
depression, 40% had aggression, 39% had anxiety, and 39%
had sleep disorders [7]. Similarly, patients with TBI fre-
quently experience agitation (11–70%), aggression (25–
39%), irritability (29–71%), alcohol abuse (7–26%), drug
abuse (2–20%), apathy (20–71%), depression (12–76%),
anxiety (0.8–24.5%), post-traumatic stress (11–18%), and
obsessive-compulsive disorder (1.2–30%) [8]. Thus, inter-
ventions aimed at cognitive symptoms that are also tar-
geted at improving quality of life (QoL) of patients with
ADRD and patients with TBI are urgently needed.
Concurrent with the increasing number of patients with
ADRD and/or TBI, more than 16 million civilians in the
United States provide unpaid care for someone with ADRD,
accounting for 83% of the care these patients receive [9].
There also are approximately 5.5 million U.S. military care-
givers of veterans, of whom 1.1 million are caring for post-
9/11 veterans [10]. Growing evidence indicates that family
caregivers of patients with ADRD and TBI provide more as-
sistance with activities of daily living (ADL) and spend more
time on the management of the patients’ safety and behav-
ioral symptoms than caregivers of people without cognitive
impairments [11, 12]. Additionally, caregivers face daunting
tasks of ensuring access to care by identifying and coordin-
ating supportive services, facilitating health care visits, advo-
cating for veterans, and serving as a proxy for health care
and financial decisions. Thus, collaborative partnerships be-
tween health care professionals, specifically in primary care,
and informal caregivers are crucial for the comprehensive
management of these veterans [12].
The burden and stress experienced by ADRD and TBI
caregivers are often higher than for caregivers of individuals
with physical disabilities [13]. Specifically, caregivers of indi-
viduals with brain disorders experience poorer health out-
comes, both physical and emotional, resulting in higher
health care use than for other caregivers. They also spend
significantly more hours per week providing care [13]. As a
result, they experience excessive emotional burden and are
at higher risk of depression than other caregivers. ADRD
and TBI caregivers also report significantly greater employ-
ment complications, including having to retire early, turn-
ing down a promotion, losing benefits, and in turn financial
hardship [13].
Early intervention can improve the QoL and functional
outcomes of patients with ADRD and TBI, resulting in re-
duced health care costs [14, 15]. Most interventions tar-
geting patients with ADRD or patients with TBI have
focused on cognitive rehabilitation techniques to improve
learning, memory, and performance of ADL/instrumental
ADL, such as psychoeducational and psychotherapeutic
approaches and integrated behavioral health programs
[16]. Although research supports these interventions, few
have been validated through randomized controlled trials.
Given the significant overlap in needs of ADRD and TBI
caregivers, many caregiver interventions have been tested
in both populations. Interventions focused on caregiver
education have been shown to improve caregiver confi-
dence [17], delay time to nursing home placement [18],
and improve caregiver health [19]. Additionally, interven-
tions that go beyond education to include behavioral man-
agement, cognitive training, and collaborative care
management have demonstrated reduced caregiver phys-
ical morbidity [20], depression and depressive symptoms
[10, 21], and anger and fatigue [22]. Interventions aimed
at the physical health and well-being of caregivers have re-
vealed that support and activity interventions improve
caregivers’ physical health [23] as well as QoL and overall
subjective well-being [10]. Further interventions aimed at
caregivers’ well-being also have demonstrated that the ex-
perience of caregiving can add meaning to their lives
through opportunities to deliver something important to a
family member they love [20, 24].
Although the efficacy of interventions for caregivers has
been well studied and holds promise to reduce caregiver
burden, few studies have taken the next steps in testing the
optimal strategies of scaling evidence-based interventions
and embedding them into existing Veterans Health Admin-
istration (VHA) primary care. To fill the translational gap
between clinical care in the research setting and real com-
munity practice, our research team is conducting a random-
ized controlled trial, the Aging Brain Care Acquiring New
Skills While Enhancing Remaining Strengths (ABC AN-
SWERS) study, to examine the impact of integrating two
evidence-based programs: a macro, systems-based collab-
orative care intervention (ABC Program) and a micro,
strength-based intervention (ANSWERS) [2, 4, 10, 25–32]
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into one program delivered within primary care. The pri-
mary outcome is caregivers’ QoL. Secondary caregiver out-
comes include symptoms of depression and anxiety, dyadic
strain, and caregiver burden. Secondary veteran outcomes
are symptoms of depression and anxiety. We hypothesize
that caregivers in dyads randomized to the ABC ANSWERS
program will experience higher levels of QoL and lower
levels of depressive and anxiety symptoms, dyadic strain,
and caregiver burden at 12months than those receiving
usual VHA primary care. Additionally, we hypothesize that
veterans randomized to the ABC ANSWERS program will
experience higher levels of QoL and lower levels of depres-
sive and anxiety symptoms at 12months than those receiv-
ing usual VHA primary care.
Methods
ABC ANSWERS study design
ABC ANSWERS is a 3-year randomized controlled trial
that includes 200 dyads, comprised of a veteran with a
diagnosis of ADRD or TBI and the veteran’s primary in-
formal caregiver. Within each stratum defined by the vet-
eran’s primary diagnosis (ADRD or TBI), dyads are
randomized 1:1 to receive ABC ANSWERS or usual pri-
mary care provided by VHA Patient Aligned Care Teams
(PACTs). Each dyad is followed for 12months. An over-
view of the study design is depicted in Fig. 1. This study
protocol has followed the Standard Protocol Items: Rec-
ommendations for Interventional Trials (SPIRIT) state-
ment guidelines (Additional file 1). The trial will be
conducted and reported according to the reporting of
pragmatic trials in an extension of the Consolidated Stan-
dards of Reporting Trials (CONSORT) statement. The
study has been approved by the institutional review board
(IRB) of Indiana University (IRB 1706902669R001); the In-
dianapolis Veteran Affairs Medical Center VA Research
Subcommittee; and the U.S. Army Medical Research and
Material Command, Office of Research Protections, Hu-
man Research Protection Office (HRPO AZ160032).
Setting and study population
The ABC ANSWERS trial is being conducted in primary
care clinics affiliated with a level 1 complexity VA med-
ical center in the Midwest. Recruitment for ABC AN-
SWERS occurs through VHA primary care PACTs and
PACTs at affiliated community-based outpatient clinics,
in which about 60% of the population are veterans living
in rural areas. We also recruit from the PACTs at the
extender primary clinic.
Eligibility
Inclusion criteria
Veterans are included if they (1) have an ADRD or TBI
diagnosis at any stage or level of impairment of their ill-
ness, (2) receive primary care services from VHA, (3)
can identify a study partner who is a family or friend
caregiver, (4) do not reside in a nursing home, (5) speak
and read English, and (6) have access to a telephone.
Caregivers are included if they (1) have been identified
as the primary person who provides, or would provide if
needed, the majority of assistance to the individual; (2)
have plans of providing care at least for 1 year or longer;
(3) are available to participate in the intervention proto-
col with veterans; (4) read and speak English; and (5)
have access to a telephone.
Exclusion criteria
Veterans and caregivers are excluded if they either are <
18 years in age, were not contacted within ten phone calls,
deny that they have ADRD or a TBI, have difficulty hear-
ing or speaking by telephone, have a terminal illness, have
a history of hospitalization for alcohol or drug abuse or se-
vere mental illness (e.g., suicidal tendencies, severe un-
treated depression or bipolar disorder, or schizophrenia),
or are a prisoner or under house arrest. Caregivers also
are excluded if they do not consider themselves an infor-
mal caregiver (e.g., believe that the veteran is not impaired
or does not support them in any capacity) or if they have
a serious medical illness limiting their ability to participate
(e.g., suicidal tendencies, severe untreated depression or
bipolar disorder, or schizophrenia).
Recruitment and randomization
We use a computer-generated randomization scheme cre-
ated by the study statisticians that is stratified by veterans’
primary diagnosis (ADRD versus TBI) to assign dyads ra-
ther than providers or clinics to the intervention or con-
trol group. Randomization at the dyad level minimizes the
effects of unmeasured case mix differences and clinic-level
clustering. Based on data from our other randomized
studies and the literature, the risk for “spillover” from hav-
ing participating clinics treat both intervention and usual
care patients is likely to be small [27, 33, 34].
Description of the intervention
ABC ANSWERS has two main goals: (1) comanage and
support the practice of primary care providers (PCPs) to
care for persons with ADRD or TBI (macro, system-level
change) and (2) enhance self-management skills of the
caregiver and veteran to maximize their coping behaviors
by building on the dyads’ strengths and abilities while
compensating for cognitive and functional losses (micro,
dyad-level change). The intervention components provide
the ability to integrate and connect various ADRD and
TBI resources available and are motivated by ADRD care
quality standards [35, 36] and supplemented with chronic
disease management approaches primarily directed to
caregivers. The intervention produces standardized, com-
prehensive assessments to develop and implement care
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goals and “set the stage” for VHA PACTs. PACT mem-
bers are then able to conduct in-depth discussions, pri-
marily with caregivers, to identify symptoms impacting
QoL and caregiver burden.
The program has three main phases: an initial assessment
phase, a strength-based collaborative care plan develop-
ment phase, and an ongoing collaborative care manage-
ment phase. By design, the protocol addresses a wide range
of care needs and results in a tailored intervention approach
for individual veterans and their caregivers. The program
components derive from several core strategies essential for
successful care management:
1. Building a relationship and trust with dyads to
increase engagement
2. Using a strength-based approach to establish goals
that are meaningful and achievable for dyads and
the respective care team members
3. Use of brief, structured validated assessments that
are comprehensive to increase scalability
4. Increasing “on-demand” caregiver access to
program resources
5. Ensuring flexibility in relationships with primary
care physicians in establishing allocation of
responsibility
6. Ensuring standards of expertise that cover a range
of biopsychosocial needs to support the dyads via
interdisciplinary care management teams
The program attempts at least one in-person home visit
with the dyad and the ABC ANSWERS team during the
first 4 weeks after enrollment, supplemented by at least
monthly calls for the first 8 weeks and bimonthly calls dur-
ing the remaining months. Supplemental phone calls can
be scheduled with the dyad on an as-needed basis or as di-
rected through the results of the ANSWERS action plan.
Initial assessment phase
The ABC ANSWERS team is structured to maximize the
skill sets of specially trained nurses and community health
workers who function as care managers (CMs) and CM
assistants in a collaborative model with the primary care
team to maximize effectiveness in improving QoL and de-
creasing caregiver burden. The team is supervised by a
physician with expertise in caring for patients with cogni-
tive disorders. The intervention team conducts a biopsy-
chosocial needs assessment in person or by phone upon
enrollment. This assessment includes a demographic and
psychosocial interview focused on achieving problem
identification. The program uses standardized assessment
tools including the Healthy Aging Brain Care Monitor
[37]. The team focuses on problem clarification and re-
views the assessment findings, medical records, medica-
tion lists, and other associated assessments. If the veteran
has unspecified cognitive issues as a diagnosis, the CM
also reviews diagnostic testing, brain imaging results, and
functional details of the assessment to determine the pres-
ence or absence of a likely dementia or TBI diagnosis and
to identify reversible and comorbid conditions. The team
creates an initial plan and identifies areas needing further
assessment after the initial home visit. For complex cases,
the registered nurse will assess need for referral for further
Fig. 1 Aging Brain Care Acquiring New Skills While Enhancing Remaining Strengths study design
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evaluation with mental health, neurology, or geriatrics
professionals. Feedback from the initial assessment and
home visit are forwarded to the veteran’s PCP with re-
quested feedback and further direction as needed.
Collaborative, strength-based care plan development phase
This phase starts after the initial home visit and concludes
with the delivery of the nine ANSWERS sessions (Table 1).
The goal of this phase is to create an individualized care
plan in collaboration with the veteran’s primary care team.
After the initial assessment is completed, any urgent med-
ical, behavioral, and/or psychological issues are addressed
through consultation with the program ADRD and TBI
specialists, as well as with the PCP as needed. During the
second visit (in home or by phone), the team reviews the
proposed care plan and identified problem list and seeks in-
put from the dyad in prioritizing care issues. From this
resulting consensus, the CM discusses the proposed indi-
vidualized care plan; explains the diagnosis (ADRD or TBI)
and natural history; implements appropriate care protocols;
reviews, explains, and distributes the corresponding educa-
tional handouts for the dyad; and connects veterans and
caregivers to eligible services and community resources.
Once all urgent needs have been addressed and the care
plan is established, the team initiates the first ANSWERS
session, shown in Table 1. Each ANSWERS session consists
of a 60- to 90-min structured curriculum that provides edu-
cation, counseling-based skills, and cognitive rehabilitation
techniques to veterans and their caregivers for coping with
and managing ADRD and TBI. At the end of each session,
the ABC ANSWERS team members and the dyad create an
action plan, which outlines specific skills and sets of activ-
ities that will be practiced until the next session. The action
plan states how often a technique should be practiced, de-
fines roles of the veteran and caregiver in practicing each
technique, and provides space to document progress and
barriers. Sessions 1–6 focus on key topic areas (see Table
1), and sessions 7–9 serve as “booster sessions” that are
conducted over the phone to assist with the maintenance,
modification, and generalization of skills.
Follow-up phase
During the follow-up phase, the CM team continues to
work with the dyad as outlined by the ANSWERS action
plan and based on presenting needs and circumstances.
The CM team answers any questions generated from pre-
vious visits, collects veteran and caregiver feedback, has
the caregiver complete a brief assessment to identify need
for specific care protocols, and facilitates caregivers’ par-
ticipation in an array of community services that are read-
ily available. The CM reconciles medications and reviews
medication adherence during both home visits or by
phone. Throughout the duration of the follow-up phase,
the team continues to work with the dyad and the
veteran’s primary care team to monitor, implement, and
adjust the individualized care plan as necessary.
Description of the control
Control group participants do not receive the ABC AN-
SWERS intervention but receive routine VHA primary
care and standardized, written educational and resource
information. The written material covers various topics
related to symptoms of ADRD and TBI, treatments,
managing the disease at home, caregiving, and VHA
community agencies that can be independently con-
tacted for assistance [38].
Primary outcome measures
Caregiver QoL is the primary outcome measure. Secondary
outcome measures include caregiver symptoms of depres-
sion, anxiety, and caregiver burden. Additional secondary
measures for the trial include veteran QoL and symptoms
of depression and anxiety. In addition to the psychosocial
outcomes data, several additional types of data addressing
the implementation and translation process also are exam-
ined. Three follow-up data collection periods occur follow-
ing the baseline (0months) data collection: short-term (3
months), intermediate (6months), and sustained (12
months) periods.
QoL
The primary outcome is QoL (Quality of Life in Alzhei-
mer’s Disease scale [QOL-AD]) measured with a 13-item
scale [39, 40] designed to provide both a patient report
and a caregiver report of QoL [39, 40]. Responses are
structured in a four-choice format (i.e., poor, fair, good, or
excellent) that is consistent across all questions, and all
items are rated according to the caregiver’s or veteran’s
current QoL. The scale includes appraisal of physical
QoL, mood, interpersonal relationships, ability to partici-
pate in meaningful activities, financial situation, and over-
all assessment of QoL. Psychometric properties indicated
that the QOL-AD has both content validity and criterion
content validity when correlated with the Dementia Qual-
ity of Life Instrument (r = 0.69) and the EuroQol EQ-5D
scale (r = 0.54). While QOL-AD has good construct valid-
ity, both interrater reliability (Cohen’s kappa > 0.70) and
internal consistency (Cronbach’s alpha coefficient = 0.82)
were excellent [41]. In a more recent evaluation, the
QOL-AD demonstrated acceptable reproducibility at 2
weeks with intraclass correlation coefficient (ICC) > 0.80
and internal consistency with Cronbach’s alpha coefficient
> 0.70. In fact, Wolak-Thierry et al. [42] reported that the
QOL-AD was preferred over the general health dimension
of the Duke Health Profile because the QOL-AD was sig-
nificantly (P < 0.0001) more efficient in time required to
complete [41, 42].
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Caregiver burden
The Oberst Caregiving Burden Scale (OCBS) [43] is used
to measure (1) caregiving tasks and responsibilities, (2)
relationships and interpersonal support, (3) lifestyle, (4)
emotional and physical health, and (5) overall personal
impact of being a caregiver. OCBS is a reliable and valid
questionnaire that rates 15 different caregiving tasks of
informal caregivers based on perceived time and diffi-
culty of the task (e.g., providing personal and medical
care, assisting with ADRDLs, monitoring symptoms,
managing patient’s emotions and behaviors, dealing with
finances, and coordinating and seeking health services).
Each item is scored on a 5-point response scale. In re-
sponse to time for each task, the caregiver chooses an
amount ranging from no time to a great deal of time
spent on the task related to caregiving. In response to
difficulty for each task, the caregiver chooses a value
ranging from not difficult to extremely difficult. Simi-
larly, there is a subscale regarding level of distress asso-
ciated with each task.
Subscale scores for perceived time, difficulty, and dis-
tress will be obtained by summing across the 15 items
scored 1 to 5. Thus, subscale scores will have a range of
15–75, with higher values indicating more perceived
time, difficulty, and distress with caregiving tasks. Evi-
dence of reliability, content validity, and construct valid-
ity for the OCBS were reported in prior studies of
ADRD [44–46] and TBI [47] family caregivers and
people caring for persons receiving cancer treatment
[48–50]. Acceptable internal consistency reliability also
has been reported in the context of family caregivers of
stroke survivors [51, 52].
Depressive and anxiety symptoms
We use the 10-item Center for Epidemiologic Studies De-
pression Scale (CES-D) [53–55] to determine the impact
of the ABC ANSWERS intervention on caregivers’ and
veterans’ depression. The CES-D is a 10-item depression
scale with a total score ranging from 0 to 30, with higher
scores indicating more symptoms of depression and a
score ≥ 10 indicating depression [55]. To measure anxiety
Table 1 Aging Brain Care Acquiring New Skills While Enhancing
Remaining Strengths intervention content
Topic Materials
1 Introduction of project,
format of sessions, and goals
Overview of educational information
about communication, cognitive or
thinking abilities, roles, and social
activities
Strength-based assessment
Skills checklist
Review of strength/skills
Session evaluation
2 Review of session 1
Introduction to effective
communication skills
Difficulties in communication
Communication skills and
techniques
Supplementary session
worksheets
Examples of skills include
patience and acceptance,
compromising, KISS, rephrasing
questions, redirection with
verbal and/or physical cues,
narrowing the choices (closed-
ended questions), and
connecting with others (open-
ended questions)
Session evaluation
Action plan
3 Review and discuss session
2 action plan
Introduction to cognitive
engagement
Discussion tools, tips, and
strategies of cognitive
engagement
Review session 2 action plan
Examples of skills include
giving hints, spaced retrieval,
and external memory aids (i.e.,
signs, lists)
Supplementary session
worksheets
Session evaluation
Action plan
4 Review and discuss session
3 action plan
Introduction to understanding
emotions and behaviors
Review session 3 action plan
Examples of skills include
cognitive task analysis,
building on and using
previously learned skills, and
the activity notebook for
cognitive stimulation and
engagement
Action plan
5 Review and discuss session
4 action plan and reflection
Cognitive techniques to
manage emotions and behaviors
Review of skills from sessions
2 and 3
Review session 4 action plan
Skills include validation,
reframing, reevaluating
expectations, giving yourself
permission, substituting
behaviors, adjusting the
environment, and making time
to relax
Supplementary session
worksheets
Session evaluation
Action plan
6 Review and discuss sessions
4 and 5 action plans
Introduction to managing
role changes and social activities
Skills and techniques to support
roles and activities
Review of action plan
Examples of skills include
simplifying activities and
routines, pleasant activities
assessment, increasing
pleasant activities
Supplementary session
worksheets
Session evaluation
Action plan
7 Review and discuss session
6 action plan
Advanced practice for care
partners
Review of action plan
Session evaluation
Action plan
Table 1 Aging Brain Care Acquiring New Skills While Enhancing
Remaining Strengths intervention content (Continued)
Topic Materials
8 Review and discuss session
7 action plan
Session wrapup and future
action plans
Review of action plan
Session evaluation
Overall program evaluations
Action plan
9 12-week booster session
Review and discuss session
8 action plan
Session wrapup and future
action plans
Review of action plan
Session 9 evaluations
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symptoms, we use the Generalized Anxiety Disorder 7-
item scale (GAD-7), which is a 7-item anxiety scale with a
total score ranging from 0 to 21 [56]. Both the CES-D and
the GAD-7 have good internal consistency and test–retest
reliability, as well as convergent, construct, criterion, pro-
cedural, and factorial validity for the diagnosis of major
depression and general anxiety disorder [56–58]. We have
used both instruments in multiple research studies, in-
cluding our dementia collaborative care trials [2, 4, 10,
25–28, 30, 31, 56, 57].
Other measures
In addition to the primary and secondary measures de-
scribed above, we also will measure caregiver and veteran
satisfaction with life [59–62]; caregiver’s emotional and
physical health strain, feelings of dyadic strain, and role cap-
tivity; and the amount of veteran’s distress experienced due
to difficulties experienced in completing ADL [63–66].
Data collection
Research assistants collect survey data by phone or in per-
son at the VHA and are blinded to which condition par-
ticipants are assigned. Caregivers and veterans are
interviewed separately, and each assessment lasts approxi-
mately 35–45min. Research assistants use protocols
followed in prior studies to facilitate veterans’ comprehen-
sion and participation [67]. Once the assessments are
completed, veterans and their caregivers receive $20 gift
cards to compensate them for their time in participating
in each study interview. To promote participant retention,
research assistants call both members of the study dyad to
schedule a convenient time to complete outcome assess-
ments. The research team will attempt to contact partici-
pants ten times during the 4-week outcome assessment
time frame. If a dyad withdraws from the study before
their 12-month duration is over, they will no longer be
pursued for outcome data. Any outcome data gathered
from the dyad while they were enrolled and active in the
study will be used for the analyses.
Research assistants attend a 1-day comprehensive train-
ing session lead by the principal investigator (PI) and
complete two practice interviews with the PI or a coinvesti-
gator who is observing. Training includes all procedures,
questionnaires, and the written manual as a reference guide.
Topics covered during the training include human subject
protection, secure data management, VHA suicide protocol
and informed consent, Health Insurance Portability and
Accountability Act (HIPAA; Public Law 104–191) guide-
lines, confidentiality of responses, techniques for interview-
ing older adults and individuals with ADRD and TBI, and
protocols for interviewer assignments and returning com-
pleted interviews. All data assessments are reviewed and
verified by a second team member before being finalized in
the secure RedCap database that sits behind the VHA
firewall. Data safety and monitoring will occur at the
monthly investigators group meeting. This group will
monitor recruitment, enrollment, data collection, interven-
tion procedures, and participant safety issues such as ad-
verse events and protocol deviations on an ad hoc basis.
This is a minimal risk study, and we do not anticipate any
study-related serious adverse events. However, we will track
all adverse events and will report any serious adverse events
to the IRB as a reportable VHA event per VHA policy. At
continuing review, the IRB will receive a copy of all adverse
events not requiring prompt reporting. PHI will not be
shared during data safety and monitoring discussions.
Analysis plan
Randomization results will be compared with a preplanned
randomization schedule to ensure randomization integrity.
To verify comparability of the randomized groups, baseline
characteristics (age, sex, race, and education level) will be
compared between randomized groups for veterans and
caregivers separately as well as veterans’ comorbid medical
conditions, the Charlson comorbidity index, number of pri-
mary care visits, and acute care use during the year prior to
enrollment. This analysis will be conducted using analysis
of covariance models for continuous variables and the
Cochran-Mantel-Hansel statistic for categorical variables
while controlling for the stratification variable of primary
diagnosis (ADRD or TBI). The distributions of continuous
variables will be examined, and transformation or nonpara-
metric methods will be used in cases of violation to the
normal distribution assumption. In addition, the frequency
distribution will be examined for all categorical variables,
and exact inference procedures will be used in cases of zero
or small cell size. All analyses will be conducted with SAS
9.4 software (SAS Institute, Cary, NC, USA).
Mixed effects models will be used with longitudinally col-
lected QoL scores from veterans as the dependent variable,
and randomization group, time, and interaction between
group and time as the independent variables while adjust-
ing for the stratification variable of primary diagnosis
(ADRD or TBI) and baseline variables that are found to be
different between the two groups. An unstructured vari-
ance–covariance matrix will be used in the mixed effects
model to adjust for potential correlations among measures
obtained from the same individual over time. A significant
interaction between group and time would indicate differ-
ences in QoL changes over time between the ABC AN-
SWER and control groups. Linear contrasts will be used to
compare the QoL scores at each follow-up time between
the two groups. Absent significant interaction, significant
main group effects would suggest differences in QoL mea-
sures between the two groups across all follow-up times.
Parametric estimation and inference procedures for the
mixed effects models are conducted using the maximum
likelihood approach with robust parametric estimation and
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inference under many missing data mechanisms [68]. In
addition, other covariates will be included in the mixed ef-
fects models to determine whether specific family member
characteristics (e.g., relationship to veteran, frequency or
types of contact, other people living in the household) are
associated with QoL changes over time. Similar analysis will
be conducted for the outcome of caregiver QoL.
Additionally, a mixed effects model will be conducted
with caregiver QoL as the outcome variable and veterans’
QoL measures as an additional independent variable to
determine how much of the intervention effect on care-
giver QoL is mediated through changes in veterans’ QoL
measures. By realigning veteran QoL and caregiver QoL,
we can also determine whether any mediation effect from
veteran QoL is concurrent or has lagged in time.
Similar linear mixed models will be fit for outcomes of
caregiver burden (OCBS) and outcomes collected on
both veteran and caregiver: depression (CES-D), anxiety
(GAD-7), and dyadic strain (dyadic relationship strain
and role captivity). All veteran and caregiver outcomes
will be fit with separate models. Linear contrasts ob-
tained from the models will be the differences in mean
score between the intervention group and the control
group at each follow-up time.
For dyad analyses, we will use the dyadic nature of the
study design and assess how caregivers’ outcomes are re-
lated to veterans’ measures. We will first explore the degree
of concordance between paired veteran–caregiver reports
using mixed effects models with concurrent veterans’ mea-
sures from the same time points as measures of caregivers.
ICCs between veteran and caregiver measures will be calcu-
lated to assess the degree of chance-corrected agreement
between individual veteran and caregiver outcomes, control-
ling for within-person correlations over time. Mixed effects
models will also be used to explore potential mediation ef-
fect of the intervention on caregivers’ outcomes from the ef-
fect on veterans’ outcomes. For example, we will examine
whether intervention effect on caregiver QoL, burden score,
and depressive or anxiety symptoms is mediated by an in-
crease in veterans’ QoL or decreased depressive or anxiety
symptoms in the intervention group versus the control
group. No interim analyses are planned.
Statistical power
Power estimation was conducted using the GLMPOWER
procedure in SAS 9.4 software, which takes into account
the repeated measures. Power was estimated under two
scenarios for potential intervention effects for the primary
outcome of veteran QoL. In the first scenario, we assume
an early intervention effect with a 0.3 standard deviation
(SD) effect size at 3 months and sustained intervention ef-
fects of 0.3 SD at 6 and 12months. In the second scenario,
we assume that the effect of intervention is gradual in a
dose–response fashion (i.e., 0.17 SD, 0.34 SD, and 0.68 SD
effect sizes at 3, 6, and 12months, respectively). We fur-
ther assumed a Toeplitz pattern for the correlation struc-
ture with correlations of 0.4 for adjacent measures and 0.2
for measures farther apart. With the total enrollment of
200 veteran–caregiver dyads, we expect 10% loss to
follow-up rate due to refusal or death. With 180 veteran–
caregiver dyads remaining, both scenarios will have > 80%
power to detect an intervention effect from a linear mixed
model with type I error set at 0.05. Power will be similar
for other aims.
Dissemination plan
A detailed study protocol will be published in an open-
access journal. Any modifications made to the protocol
will be communicated to Indiana University, Veteran Af-
fairs Medical Center Indianapolis VA Research Subcom-
mittee, and U.S. Army Medical Research and Material
Command, Office of Research Protections. The findings of
this study will also be presented at scientific conferences.
Also, a manuscript will be prepared and submitted to a
peer-reviewed scientific journal for possible publication.
Discussion
Over the past 20 years, interventions aimed at improving
QoL for caregivers and patients and reducing caregiver
burden have moved progressively, but separately, from
testing educational and skills training to cognitive training
for persons with cognitive impairment and to complex
collaborative care models [2, 4, 10, 25–28, 30–32, 56, 57].
This progression has created both micro (patient–care-
giver dyad-focused) and macro (population health–fo-
cused) interventions that have brought a greater number
of resources into primary care. Unfortunately, research
also has revealed practical constraints of time and space
and lack of expertise in caring for people with ADRD and
TBI within the primary care environment. Thus, new
models of care are moving toward a view of primary care
as the “hub of care” (e.g., PACTs), which is the corner-
stone of the new models of care transformation in VHA
[2, 69, 70]. One implication of this paradigm shift is that
models of care for people with ADRD and TBI must be
expanded to include key components of population brain
health that are implemented collaboratively in primary
care. However, these models have not been widely
adopted, because they require a redesign of the practice
environment and partnerships with the health care system
that support practice redesign.
VHA PACTs provide the ideal environment to test
these new models of collaborative care for ADRD and
TBI. Thus, we have designed ABC ANSWERS to assist
the PACTs in achieving recommended standards of care
through evaluation and management of patients with
ADRD and TBI and to support and improve the coping,
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well-being, and independence of veterans with ADRD
and TBI and their caregivers.
The ABC ANSWERS intervention integrates the com-
mon features of an evidence-based collaborative care
model for brain care while also attending to the imple-
mentation barriers of delivering care and skills to dyads of
veterans with ADRD or TBI and their caregivers. To date,
our work has resulted in significant improvement in the
quality of care and management of behavioral and psycho-
logical symptoms for patients and their caregivers, and it
has significantly reduced caregivers’ strain and improved
caregivers’ well-being and their sense of mastery in a care-
giver role [2, 4, 10, 25–28, 30–32, 56, 57].
The ABC ANSWERS trial has some limitations. The
most significant threat may be lack of ability to recruit be-
cause of the underdetection of ADRD and TBI among vet-
erans. This would limit our ability to recruit dyads in which
a veteran has one of these conditions and could be enrolled
[71, 72]. To address this potential limitation, we have
opened recruitment from all primary care sources and in-
clude veterans who have been seen at VHA specialty clinics
and programs as long as they also receive primary care
from a VHA provider. A second possible limitation of our
study is the variable interactions between the ABC AN-
SWERS care team and the various primary care PACTs.
Findings may reflect different culture among the PACTs
and personal qualities and relationship of the team’s inter-
actions. However, a strong protocol-driven intervention
and standardized training program will limit quality and re-
producibility concerns. Furthermore, dyads randomized to
the usual primary care group may receive nonstudy ADRD
and TBI resources from their PACTs or resources from
other VHA services. However, it is unlikely that dyads will
receive management strategies that reflect the constructs in
the ABC ANSWERS intervention through their engage-
ment with the PACTs for usual care.
In summary, the tremendous need for primary care–
based interventions that are focused on dyads and aim to
improve care and outcomes for both people with ADRD
and TBI and their caregivers remains. ABC ANSWERS
aims to test the effectiveness of the intervention for im-
proving QoL and reducing burden through care coordin-
ation, psychosocial well-being outcomes, and reducing
different types of role and intrapsychic strain. The results
of this study will inform other interventions that support
patients with ADRD or TBI and their caregivers and that
are scalable and embedded in existing VA primary care.
Supplementary information
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1186/s13063-020-4199-1.
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